Verification of analytical performance of Carcinoembryonic antigen assay on the Abbott Alinity ci®: Experience of the central laboratory of Mohammed VI University Hospital of Oujda
1 Mohammed First University, Faculty of Medicine and Pharmacy of Oujda, Morocco.
2 Biochemistry laboratory of Mohammed VI University Hospital, Oujda, Morocco.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(02), 191–196.
Article DOI: 10.30574/wjbphs.2024.19.2.0512
Publication history:
Received on 26 June 2024; revised on 08 August 2024; accepted on 10 August 2024
Abstract:
The aim of our study was the verification of the analytical performance of Carcinoembryonic antigen determination on the Abbott CI analyzer utilizing the immuno-chemiluminescence method. The verification process was conducted in the biochemistry laboratory of Mohammed VI University Hospital of Oujda. The working methodology adapted is based on the recommendations of the protocol of the French accreditation committee (COFRAC) accreditation technical guide (GTA) 04, by the evaluation of reproducibility and repeatability. The results obtained by this evaluation were overall satisfactory and have meet the recommended criteria set by supplier and the French society of clinical biology. This study shows that the biochemistry laboratory of Mohammed VI University Hospital of Oujda can deliver an accurate and precise results which can be used for clinical diagnosis and decision making.
Keywords:
Carcinoembryonic Antigen; Tumor Marker; Analytical Performance; Repeatability; Reproducibility; Alinity CI Analyzer; Immuno-Chemiluminescence
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0